Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
87.35
+0.39 (0.45%)
Jul 18, 2025, 4:00 PM - Market closed
Alcon Employees
Alcon had 25,599 employees as of December 31, 2024. The number of employees increased by 284 or 1.12% compared to the previous year.
Employees
25,599
Change (1Y)
284
Growth (1Y)
1.12%
Revenue / Employee
$387,710
Profits / Employee
$43,752
Market Cap
43.49B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25,599 | 284 | 1.12% |
Dec 31, 2023 | 25,315 | 137 | 0.54% |
Dec 31, 2022 | 25,178 | 789 | 3.24% |
Dec 31, 2021 | 24,389 | 734 | 3.10% |
Dec 31, 2020 | 23,655 | 1,513 | 6.83% |
Dec 31, 2019 | 22,142 | 1,761 | 8.64% |
Dec 31, 2018 | 20,381 | 1,251 | 6.54% |
Dec 31, 2017 | 19,130 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ALC News
- 10 days ago - Alcon's Latest Breakthrough Surgical Technology, Unity VCS, receives Health Canada approval - Business Wire
- 22 days ago - Alcon Canada Earns Global Recognition as a Top Employer - Business Wire
- 23 days ago - Gordon Schanzlin New Vision Institute Becomes First U.S. Clinic to Use Alcon's Breakthrough Unity Phaco System - GlobeNewsWire
- 4 weeks ago - Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL - Business Wire
- 6 weeks ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 7 weeks ago - US FDA approves Alcon's new dry-eye drug - Reuters
- 7 weeks ago - Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease - Business Wire
- 7 weeks ago - Turkey Contact Lens Market - Competition, Forecast & Opportunities to 2030, Featuring Tech Contactlens, Diafarma, Alcon Laboratories, Diplomat Optics, Hoya Turkiye, ZEISS Turkiye, Keralens & more - GlobeNewsWire